ABSTRACT
Neuropilins (NRPs) are cell surface glycoproteins that often act as co-receptors for plexins and VEGF family receptors. Neuropilin-2 (NRP2), a family member of NRPs, was shown to regulate autophagy and endocytic trafficking in cancer cells, a function distinctly different from its role as a co-receptor. WD Repeat and FYVE domain containing 1 (WDFY1)-protein acts downstream of NRP2 for this function. Our results indicated that NRP2 maintains an optimum concentration of WDFY1 by negatively regulating its expression. Since increased expression of WDFY1 reduces the endocytic activity, maintenance of WDFY1 level is crucial in metastatic cancer cells to sustain high endocytic activity, essential for promotion of oncogenic activation and cancer cell survival. Here, we have delineated the underlying molecular mechanism of WDFY1 synthesis by NRP2. Our results indicated that NRP2 inhibits WDFY1 transcription by preventing the nuclear localization of a transcription factor, Fetal ALZ50-reactive clone 1 (FAC1). Our finding is novel as transcriptional regulation of a gene by NRP2 axis has not been reported previously. Regulation of WDFY1 transcription by NRP2 axis is a critical event in maintaining metastatic phenotype in cancer cells. Thus, inhibiting NRP2 or hyper-activating WDFY1 can be an effective strategy to induce cell death in metastatic cancer.
Subject(s)
Antigens, Nuclear/physiology , Nerve Tissue Proteins/physiology , Neuropilin-2/physiology , Nuclear Proteins/genetics , Transcription Factors/physiology , Transcriptional Activation , Adaptor Proteins, Signal Transducing , Base Sequence , Binding Sites , Cell Line, Tumor , Humans , Nuclear Proteins/metabolism , Promoter Regions, Genetic , Protein Binding , Protein Stability , Protein Transport , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription, GeneticABSTRACT
Neuropilin-2 (NRP2) is a non-tyrosine kinase receptor frequently overexpressed in various malignancies, where it has been implicated in promoting many protumorigenic behaviors, such as imparting therapeutic resistance to metastatic cancer cells. Here, we report a novel function of NRP2 as a regulator of endocytosis, which is enhanced in cancer cells and is often associated with increased metastatic potential and drug resistance. We found that NRP2 depletion in human prostate and pancreatic cancer cells resulted in the accumulation of EEA1/Rab5-positive early endosomes concomitant with a decrease in Rab7-positive late endosomes, suggesting a delay in early-to-late endosome maturation. NRP2 depletion also impaired the endocytic transport of cell surface EGFR, arresting functionally active EGFR in endocytic vesicles that consequently led to aberrant ERK activation and cell death. Mechanistic investigations revealed that WD-repeat- and FYVE-domain-containing protein 1 (WDFY1) functioned downstream of NRP2 to promote endosome maturation, thereby influencing the endosomal trafficking of EGFR and the formation of autolysosomes responsible for the degradation of internalized cargo. Overall, our results indicate that the NRP2/WDFY1 axis is required for maintaining endocytic activity in cancer cells, which supports their oncogenic activities and confers drug resistance. Therefore, therapeutically targeting endocytosis may represent an attractive strategy to selectively target cancer cells in multiple malignancies.
Subject(s)
Endosomes/metabolism , ErbB Receptors/metabolism , Neoplasms/genetics , Neuropilin-2/genetics , Neuropilin-2/metabolism , Cell Line, Tumor , Humans , Neoplasms/pathologyABSTRACT
Solid acid catalysts can hydrolyze cellulose with lower reaction times and are easy to recover and reuse. A glycerol based carbon acid catalyst developed at CSIR-IICT performed well in acid catalysis reactions and hence this study was undertaken to evaluate the catalyst for hydrolysis of biomass (alkali pretreated or native rice straw). The catalyst could release 262 mg/g total reducing sugars (TRS) in 4h at 140 °C from alkali pretreated rice straw, and more importantly it released 147 mg/g TRS from native biomass. Reusability of the catalyst was also demonstrated. Catalytic hydrolysate was used as sugar source for fermentation to produce ethanol. Results indicate the solid acid catalyst as an interesting option for biomass hydrolysis.
Subject(s)
Biomass , Biotechnology/methods , Carbon/chemistry , Ethanol/chemistry , Carbohydrates/chemistry , Catalysis , Fermentation , Glycerol/chemistry , Hydrolysis , Oryza , Saccharomyces cerevisiae/enzymology , TemperatureABSTRACT
A major contributor to cancer mortality is recurrence and subsequent metastatic transformation following therapeutic intervention. Therefore, in order to develop new treatment modalities and improve the efficacy of current ones, it is important to understand the molecular mechanisms that promote resistance to therapy in cancer cells. One pathway contributing to therapy resistance is autophagy, a self-digestive process that can eliminate unnecessary or damaged organelles to protect cancer cells from death. We have found that the VEGF-C/NRP-2 axis is involved in the activation of autophagy, which helps cancer cell survival following treatment. Inhibition of mTOR complex 1 activity by this axis is the underlying mechanism for the activation of autophagy. Furthermore, we identified two VEGF-C/NRP-2-regulated genes, LAMP-2 and WDFY-1, that have previously been suggested to participate in autophagy and vesicular trafficking. Upregulation of WDFY-1 following VEGF-C or NRP-2 depletion contributes to cytotoxic drug-mediated cell death. Together, these data suggest a link between the VEGF-C/NRP-2 axis and cancer cell survival despite the presence of chemotherapy-induced stress. Effective targeting of this pathway may lead to the development of new cancer therapies.
